NUVATION BIO INC NUVB 深 滬
已收盤 09-26 16:00:00 美东时间
3.20
+0.190
+6.31%
華盛通- 最 高3.2565
- 今 開3.04
- 成交量 471.36万股
- 最 低 2.995
- 昨 收 3.01
- 總市值 10.94亿
- 52周最高 4.0899
- 市盈率 靜 --
- 換手率 1.38%
- 52周最低 1.54
- 委 比 0.00%
- 總股本 3.42亿
- 歷史最高 15.23
- 量 比 0.86
- 振 幅 8.69%
- 歷史最低 0.95
- 每 手 1
- 風險率 0.40%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 潜在涨幅302.68%！Maxim Group上调T Stamp目标价至12美元，维持"买入"评级
今日重点评级关注：Maxim Group：维持T Stamp"买入"评级，目标价从8美元升至12美元；Maxim Group：维持Rezolute"买入"评级，目标价从15美元升至20美元
09-22 18:44
Nuvation Bio Says Japan's MHLW Approves IBTROZITM For Treatment Of Adult Patients With ROS1-Positive Unresectable, Advanced And/Or Recurrent NSCLC
IBTROZI will be marketed in Japan by Nippon KayakuApproval is based on the pivotal Phase 2 TRUST studies, demonstrating IBTROZI's high rates and durability of responsesPrimary companion diagnostic approved inIBTROZI will be marketed in Japan by Nippon Kayaku
09-19 19:32
Wedbush Reiterates Outperform on Nuvation Bio, Maintains $6 Price Target
Wedbush analyst David Nierengarten reiterates Nuvation Bio (NYSE:NUVB) with a Outperform and maintains $6 price target.
09-08 21:12
美股周涨跌榜 | 医药牛股频出！细胞动力周涨幅达50%，新药迎关键进展；美国联合医疗周涨超31%
医药牛股频出！细胞动力周涨幅达50%，新药迎关键进展；美国联合医疗周涨超31%，肺纤维化治疗取得重大突破；Lululemon周跌17%，此前下调年度利润及销售额预期>>
09-06 10:02
Guidewire Software, Samsara, Zumiez And Other Big Stocks Moving Higher On Friday
U.S. stocks were lower, with the Dow Jones index falling over 200 points on Fri...
09-06 01:29
Top 2 Health Care Stocks That May Plunge This Month
As of Sept. 5, 2025, two stocks in the health care sector could be flashing a r...
09-05 22:39
Nuvectis Pharma to Participate at the H.C. Wainwright 27th Annual Global Investment Conference
Nuvectis Pharma, Inc. announced its participation in the upcoming H.C. Wainwright Global Investment Conference. Ron Bentsur, the company's CEO, will deliver a presentation on September 5, 2025, available for on-demand viewing. The company will also engage in virtual one-on-one meetings from September 8-10, 2025. Nuvectis specializes in developing precision medicines for unmet medical needs in oncology, with two clinical-stage drug candidates: NXP...
09-04 11:30
美股大行评级 | 潜在涨幅286.44%！RBC Capital上调Edgewise Therapeutics目标价至49美元，维持"跑赢大市"评级
今日重点评级关注：RBC Capital：维持Edgewise Therapeutics"跑赢大市"评级，目标价从48美元升至49美元；RBC Capital：维持Nuvation Bio"跑赢大市"评级，目标价从6美元升至7美元
08-11 09:43
Nuvation Bio’s Milestone with FDA Approval of IBTROZI
Nuvation Bio Inc ( ($NUVB) ) has released its Q2 earnings. Here is a breakdown ...
08-08 12:53
Nuvation Bio Q2 2025 GAAP EPS $(0.17), Inline, Sales $4.833M Up From $1.435M YoY
Nuvation Bio (NYSE:NUVB) reported quarterly losses of $(0.17) per share which met the analyst consensus estimate. The company reported $4.833 million in sales this quarter. This is a 236.79 percent increase over sales
08-07 19:31
